Lymphopenia during Ocrelizumab treatment in multiple sclerosis: searching for causes in the context of a single centre experience

被引：0
|
作者：
Ihlefeld, Christian [1 ]
Ladwig, Anne [1 ]
Zimmermann, Olga [1 ]
Leypoldt, Frank [1 ]
Lueddecke, Robin
Stuerner, Klarissa [1 ]
机构：
[1] Univ Klinikum Schleswig Holstein, Dept Neurol, Campus Kiel, Kiel, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1651/2497
引用
收藏
页码：1045 / 1045
页数：1
相关论文
共 50 条
  • [1] Ocrelizumab in patients with multiple sclerosis: a single center experience
    Brady, C.
    Lakhani, D.
    Hou, B.
    Carpenter, J.
    Luo, W.
    Magda, S.
    Haxton, R.
    Tripathi, R.
    Deib, G.
    Sriwastava, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 176 - 177
  • [2] Pertussis during ocrelizumab treatment for multiple sclerosis
    Kabiri, Bushra
    Blount, Sophie
    Garjani, Afagh
    Evangelou, Nikos
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1046 - 1047
  • [3] Ocrelizumab-therapy associated lymphopenia is linked to age in patients with multiple sclerosis in a single-centre retrospective cohort study
    Plenge, J.
    Beyer, T.
    Leypoldt, F.
    Stuerner, K. H.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 296 - 296
  • [4] Ocrelizumab for the treatment of multiple sclerosis
    Bigaut, Kevin
    De Seze, Jerome
    Collongues, Nicolas
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (02) : 97 - 108
  • [5] Plasmapheresis as relapse treatment in relapse remitting multiple sclerosis: single centre experience
    Kleinova, P.
    Pavlickova, J.
    Horakova, D.
    Havrdova, E.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 595 - 596
  • [6] Ocrelizumab treatment in patients with progressive multiple sclerosis: a single-center real-world experience
    Cellerino, M.
    Boffa, G.
    Lapucci, C.
    Sbragia, E.
    Bruschi, N.
    Mancuso, E.
    Tazza, F.
    Poire, I.
    Laroni, A.
    Capello, E.
    Uccelli, A.
    Novi, G.
    Inglese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 295 - 295
  • [7] Ocrelizumab treatment in patients with progressive multiple sclerosis: a single-center real-world experience
    Cellerino, Maria
    Boffa, Giacomo
    Lapucci, Caterina
    Sbragia, Elvira
    Bruschi, Nicolo
    Mancuso, Elisabetta
    Tazza, Francesco
    Poire, Ilaria
    Laroni, Alice
    Capello, Elisabetta
    Uccelli, Antonio
    Novi, Giovanni
    Inglese, Matilde
    NEUROLOGY, 2021, 96 (15)
  • [8] Ocrelizumab-induced neutropenia in people with multiple sclerosis: a single-centre study
    Sartori, Arianna
    Favero, Anna
    Rossi, Lucrezia
    Dinoto, Alessandro
    Miotto, Domitilla
    Baldini, Sara
    Bratina, Alessio
    Bosco, Antonio
    Manganotti, Paolo
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 631 - 631
  • [9] Multiple Sclerosis in Pregnancy: A single centre multidisciplinary experience
    Onanuga, S.
    Mahmud, M.
    Dhanjal, M.
    Dassan, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 913 - 913
  • [10] Neutropenia after ocrelizumab treatment in patients with multiple sclerosis: a single-centre case series and systematic review of literature
    Silva, Joana Almada
    Delgado, Sofia
    Santos, Mariana
    Leitao, Lia
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1187 - 1187
12345